AMSTERDAM — Is it twilight for positive inotropic agents for acute heart failure and their daunting risks? Not necessarily, but an investigational drug that increases stroke volume apparently without ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Against ...
French centers tested the calcium-sensitizing inotrope levosimendan in patients with severe but potentially reversible cardiogenic shock recently put on VA-ECMO. Early levosimendan did not facilitate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback